Gilead Sciences, Inc.
Anti-HIV compounds
Last updated:
Abstract:
The invention provides compounds having Formula (I): ##STR00001## or a pharmaceutically acceptable salt thereof, as well as pharmaceutical compositions comprising the same, processes for their preparation, and methods of treating and preventing HIV infection by their administration.
Status:
Grant
Type:
Utility
Filling date:
29 Jul 2019
Issue date:
6 Jul 2021